Carregant...
How I treat newly diagnosed chronic phase CML
The progress made in the understanding of chronic myeloid leukemia (CML) since the recognition of a common chromosomal abnormality to the introduction of ever more effective tyrosine kinase inhibitors is unprecedented in cancer. The expected survival for patients diagnosed with CML today, if properl...
Guardat en:
| Publicat a: | Blood |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4916560/ https://ncbi.nlm.nih.gov/pubmed/22613793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-03-378919 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|